ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 127 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $29,000 | +3.6% | 19,678 | 0.0% | 0.00% | – |
| Q4 2016 | $28,000 | -37.8% | 19,678 | -24.3% | 0.00% | – |
| Q3 2016 | $45,000 | -22.4% | 25,993 | -23.4% | 0.00% | – |
| Q2 2016 | $58,000 | 0.0% | 33,947 | +14.7% | 0.00% | – |
| Q1 2016 | $58,000 | +41.5% | 29,593 | +38.0% | 0.00% | – |
| Q4 2015 | $41,000 | -28.1% | 21,450 | -27.7% | 0.00% | – |
| Q3 2015 | $57,000 | +29.5% | 29,676 | +215.1% | 0.00% | – |
| Q2 2015 | $44,000 | +37.5% | 9,418 | +28.8% | 0.00% | – |
| Q1 2015 | $32,000 | +39.1% | 7,313 | +9.8% | 0.00% | – |
| Q4 2014 | $23,000 | -30.3% | 6,659 | -16.1% | 0.00% | – |
| Q3 2014 | $33,000 | -29.8% | 7,939 | 0.0% | 0.00% | – |
| Q2 2014 | $47,000 | -9.6% | 7,939 | -4.7% | 0.00% | – |
| Q1 2014 | $52,000 | +8.3% | 8,331 | +2.1% | 0.00% | – |
| Q4 2013 | $48,000 | -69.0% | 8,160 | -72.2% | 0.00% | -100.0% |
| Q3 2013 | $155,000 | +36.0% | 29,340 | +98.1% | 0.00% | 0.0% |
| Q2 2013 | $114,000 | – | 14,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
| MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
| Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
| Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
| Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
| OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |